Philip R. Lage-Hansen

Apr 16, 2024 | acrjournals.onlinelibrary.wiley.com | Bjørk K. Sofíudóttir |Stefan Harders |Christian B. Laursen |Philip R. Lage-Hansen

INTRODUCTION Rheumatoid arthritis (RA)–associated interstitial lung disease (ILD) is clinically evident in about 2.2% to 10% of the RA population and has an increased 5-year mortality of 40% compared with matched RA controls.1, 2 In general, it is recommended that patients with RA with respiratory symptoms should receive a diagnostic workup for ILD and a chest high-resolution computed tomography (HRCT) combined with multidisciplinary team discussion (MDT), as is the gold standard for ILD...